BioMed Research International / 2018 / Article / Tab 1 / Research Article
In Vitro Antibacterial Activity of Propyl-Propane-Thiosulfinate and Propyl-Propane-Thiosulfonate Derived from Allium spp. against Gram-Negative and Gram-Positive Multidrug-Resistant Bacteria Isolated from Human SamplesTable 1 Activity in vitro of PTS, PTSO, and others antibacterial agents against gram-negative organisms.
Organisms (number of isolates) MIC 50 MIC 90 MBC 50 MBC 90 of resistant isolates (in mg/L) (in mg/L) (in mg/L) (in mg/L) Enterobacteriaceae (n=151) Amoxicillin/clavulanate 32/16 256/128 64/32 256/128 59.6 Piperacillin/tazobactam 8/4 256/4 32/4 512/4 31.8 Cefuroxime >512 >512 >512 >512 81.5 Cefoxitin 8 256 64 512 37.1 Cefotaxime 64 >128 128 >128 77.5 Ceftazidime 16 256 64 512 58.3 Cefepime 8 128 32 256 65.6 Imipenem 1 1 2 16 2.0 Meropenem 0.125 1 0.25 4 1.3 Gentamicin 4 128 32 >128 35.8 Tobramycin 4 128 32 >128 42.4 Amikacin 16 >512 64 >512 29.1 Ciprofloxacin 64 >128 128 >128 67.6 Trimethoprim/sulfamethoxazole 2/38 >64/1216 64/1216 >64/1216 53.0 Nitrofurantoín 32 256 128 512 43.0 PTS 256 512 256 512 - PTSO 64 128 128 512 - Escherichia coli (n=68) Amoxicillin/clavulanate 16/8 256/128 64/32 >256/128 55.9 Piperacillin/tazobactam 8/4 128/4 32/4 256/4 26.5 Cefuroxime >512 >512 >512 >512 95.6 Cefoxitin 8 128 32 256 33.8 Cefotaxime 128 >128 >128 >128 94.1 Ceftazidime 32 256 64 >512 75.0 Cefepime 16 128 64 256 80.9 Imipenem 0.5 1 2 4 0.0 Meropenem 0.06 1 0.125 4 0.0 Gentamicin 4 64 16 128 30.9 Tobramycin 4 64 16 128 33.8 Amikacin 8 32 32 128 14.7 Ciprofloxacin 64 128 128 >128 73.5 Trimethoprim/sulfamethoxazole >64/1216 >64/1216 >64/1216 >64/1216 61.8 Nitrofurantoin 32 64 64 256 14.7 PTS 128 256 256 512 - PTSO 64 128 128 512 - Klebsiella spp. (n=39) Amoxicillin/clavulanate 32/16 64/32 64/32 256/128 82.1 Piperacillin/tazobactam 32/4 512/4 64/4 >512/4 59.0 Cefuroxime >512 >512 >512 >512 97.4 Cefoxitin 32 512 64 >512 53.8 Cefotaxime 64 >128 128 >128 97.4 Ceftazidime 64 256 128 512 76.9 Cefepime 16 64 32 256 79.5 Imipenem 1 1 2 4 0.0 Meropenem 0.06 0.25 0.125 1 0.0 Gentamicin 64 >128 64 >128 66.7 Tobramycin 32 >128 32 >128 76.9 Amikacin 64 >512 128 >512 53.8 Ciprofloxacin 128 >128 >128 >128 87.2 Trimethoprim/sulfamethoxazole >64/1216 >64/1216 >64/1216 >64/1216 79.5 Nitrofurantoin 64 128 128 256 61.5 PTS 256 512 256 512 - PTSO 128 256 128 512 - ESBL-producers (n=59) Amoxicillin/clavulanate 16/8 >256/128 64/32 >256/128 52.5 Piperacillin/tazobactam 8/4 256/4 32/4 512/4 30.5 Cefuroxime >512 >512 >512 >512 100 Cefoxitin 8 64 32 128 25.4 Cefotaxime 128 >128 >128 >128 100 Ceftazidime 64 256 256 >512 78.0 Cefepime 32 128 64 >256 93.2 Imipenem 0.5 1 2 4 0.0 Meropenem 0.125 1 0.25 4 0.0 Gentamicin 4 128 16 >128 37.3 Tobramycin 4 128 32 >128 47.5 Amikacin 16 128 64 128 25.4 Ciprofloxacin 64 >128 128 >128 74.6 Trimethoprim/sulfamethoxazole >64/1216 >64/1216 >64/1216 >64/1216 62.7 Nitrofurantoin 32 128 64 256 32.2 PTS 128 256 256 512 - PTSO 64 128 128 512 - Salmonella spp. and Yersinia spp. (n=32) Amoxicillin/clavulanate 8/4 256/128 64/32 256/128 28.1 Piperacillin/tazobactam 2/4 128/4 16/4 128/4 12.5 Cefuroxime 4 >512 32 >512 25.0 Cefoxitin 8 64 64 128 12.5 Cefotaxime 1 1 8 64 12.5 Ceftazidime 4 4 16 64 0.0 Cefepime 2 32 16 64 0.0 Imipenem 1 1 16 16 0.0 Meropenem 1 1 4 8 0.0 Gentamicin 4 4 32 32 3.1 Tobramycin 4 4 32 32 6.3 Amikacin 16 128 128 256 34.4 Ciprofloxacin 1 128 8 128 37.5 Trimethoprim/sulfamethoxazole 2/38 2/38 16/304 >64/1216 3.1 Nitrofurantoin 256 512 512 1024 65.6 PTS 256 256 256 512 - PTSO 64 128 64 128 - Remaining enterobacteria (n=12) Amoxicillin/clavulanate 64/32 128/64 256/128 256/128 91.7 Piperacillin/tazobactam 4/4 64/4 8/4 256/4 25.0 Cefuroxime >512 >512 >512 >512 100 Cefoxitin 256 >512 256 >512 66.7 Cefotaxime 64 >128 128 >128 91.7 Ceftazidime 8 128 32 512 58.3 Cefepime 8 64 8 256 66.7 Imipenem 1 4 2 16 25.0 Meropenem 0.06 1 0.125 4 16.7 Gentamicin 4 32 32 >128 50.0 Tobramycin 8 32 16 >128 58.3 Amikacin 4 256 8 >512 16.7 Ciprofloxacin 1 >128 8 >128 50.0 Trimethoprim/sulfamethoxazole 2/38 >64/1216 16/304 >64/1216 50.0 Nitrofurantoin 64 >1024 128 >1024 83.3 PTS 128 256 256 256 - PTSO 64 128 128 256 - Nonfermenting gram-negative bacilli (n=61) Piperacillin/tazobactam 16/4 512/4 128/4 512/4 34.4 Ceftazidime 8 128 64 512 32.8 Cefepime 8 32 64 256 42.6 Imipenem 16 128 32 >128 52.5 Meropenem 4 64 16 128 52.5 Gentamicin 4 >128 32 >128 39.3 Tobramycin 4 >128 32 >128 27.9 Amikacin 8 128 32 256 19.7 Ciprofloxacin 32 >128 64 >128 59.0 PTS 1024 2048 1024 2048 - PTSO 256 1024 512 2048 - Pseudomonas aeruginosa (n=40) Piperacillin/tazobactam 16/4 256/4 128/4 256/4 25.0 Ceftazidime 8 64 64 256 27.5 Cefepime 8 32 64 128 32.5 Imipenem 16 128 32 128 57.5 Meropenem 4 64 32 128 57.5 Gentamicin 4 >128 16 >128 37.5 Tobramycin 4 128 16 >128 17.5 Amikacin 8 32 32 128 12.5 Ciprofloxacin 32 >128 64 >128 62.5 PTS 1024 2048 2048 2048 - PTSO 512 1024 512 2048 - Remaining nonfermenting gram-negative bacilli (n=21) Piperacillin/tazobactam 128/4 512/4 512/4 >512/4 52.4 Ceftazidime 8 128 64 512 42.9 Cefepime 16 64 128 256 61.9 Imipenem 2 >128 16 >128 42.9 Meropenem 2 16 8 >128 42.9 Gentamicin 4 >128 32 >128 42.9 Tobramycin 4 >128 32 >128 47.6 Amikacin 16 256 64 256 33.3 Ciprofloxacin 4 >128 32 >128 52.4 PTS 128 512 128 512 - PTSO 64 256 64 256 -
MIC: minimum inhibitory concentration; MBC: minimum bactericidal concentration; % of resistant isolates: percentages of isolates intermediate or resistant according to the criteria published by the CLSI (2016).